Health disparities in rural areasSome policies and practices have led to health risks and challenges, and related long-term health outcomes, for people living in certain
The Supreme Court on Thursday declined to entertain a plea raising concerns over the government-run nationwide human papillomavirus (HPV) vaccination campaign for adolescent girls to
India aims to prevent potentially dangerous drug reactions before they reach patients, moving beyond largely retrospective reporting towards proactive drug-safety monitoring. Under a proposed framework,
Government plans to replace the Drugs & Cosmetics Act, 1940. This highlights a major regulatory shift. The Draft Drugs, Medical Devices & Cosmetics Bill, 2026
Companies reject the National Pharmaceutical Pricing Authority’s proposal that would place sole legal responsibility for overpricing on manufacturers while shielding retail chemists, hospitals and nursing
Dario Amodei recently made an unusually direct observation about the promises surrounding artificial intelligence and medicine:“At this point, saying that AI will cure cancer is
The draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes easing criminal prosecution for minor drug quality and regulatory lapses by allowing offences to be
Indian pharmaceutical firms have spent decades supplying American patients with affordable medicines. That dominance will be difficult to challenge, despite President Donald Trump’s threat to
According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains,
New Delhi: India’s pharmaceutical industry should treat the proposed US tariffs on imported generic medicines as a wake-up call to reduce dependence on a single